 | • レポートコード：D0GIR-00837 • 出版社/出版日：GlobalInfoResearch / 2020年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、自己免疫疾患診断の世界市場を広く調査・分析し、今後の市場展望をまとめております。自己免疫疾患診断の種類別市場規模（日常検査、炎症マーカー、自己抗体・免疫検査、その他検査）、用途別市場規模（関節リウマチ、全身性エリテマトーデス、シェーグレン症候群、甲状腺炎、強皮症、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Thermo Fisher Scientific、Trinity Biotech、GRIFOLS、Siemens、Abbott、Inova Diagnostics、Protagen、Bio-Rad Laboratories、Danaher、Werfen、HYCOR Biomedical、HTG Molecular Diagnostics、EUROIMMUN AG ・地域別グローバル市場分析 2015年-2020年 ・自己免疫疾患診断の北米市場（アメリカ、カナダ、メキシコ） ・自己免疫疾患診断のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・自己免疫疾患診断のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・自己免疫疾患診断の南米市場（ブラジル、アルゼンチン） ・自己免疫疾患診断の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：日常検査、炎症マーカー、自己抗体・免疫検査、その他検査 ・用途別分析：関節リウマチ、全身性エリテマトーデス、シェーグレン症候群、甲状腺炎、強皮症、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The Diagnosis of Autoimmune Diseases market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The most likely (base case) scenario is that the global Diagnosis of Autoimmune Diseases sales will be xx in 2020 from Diagnosis of Autoimmune Diseases million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Diagnosis of Autoimmune Diseases market size is expected to grow at xx% or more annually for the next five years.
This report also researches and evaluates the impact of Covid-19 outbreak on the Diagnosis of Autoimmune Diseases industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Diagnosis of Autoimmune Diseases and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
Diagnosis of Autoimmune Diseases market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Diagnosis of Autoimmune Diseases market has been segmented into:
Routine Laboratory Tests
Inflammatory Markers
Autoantibodies & Immunologic Test
Other Tests
By Application, Diagnosis of Autoimmune Diseases has been segmented into:
Rheumatoid Arthritis
Systemic Lupus Erythematosus
Sjögren’s Syndrome
Thyroiditis
Scleroderma
Other Diseases
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Diagnosis of Autoimmune Diseases market presented in the report. This section sheds light on the sales growth of different regional and country-level Diagnosis of Autoimmune Diseases markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Diagnosis of Autoimmune Diseases market.
The report offers in-depth assessment of the growth and other aspects of the Diagnosis of Autoimmune Diseases market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Diagnosis of Autoimmune Diseases Market Share Analysis
Diagnosis of Autoimmune Diseases competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Diagnosis of Autoimmune Diseases sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Diagnosis of Autoimmune Diseases sales, revenue and market share for each player covered in this report.
The major players covered in Diagnosis of Autoimmune Diseases are:
Thermo Fisher Scientific
Trinity Biotech
GRIFOLS
Siemens
Abbott
Inova Diagnostics
Protagen
Bio-Rad Laboratories
Danaher
Werfen
HYCOR Biomedical
HTG Molecular Diagnostics
EUROIMMUN AG
Among other players domestic and global, Diagnosis of Autoimmune Diseases market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 Diagnosis of Autoimmune Diseases Market Overview
1.1 Product Overview and Scope of Diagnosis of Autoimmune Diseases
1.2 Classification of Diagnosis of Autoimmune Diseases by Type
1.2.1 Global Diagnosis of Autoimmune Diseases Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Diagnosis of Autoimmune Diseases Revenue Market Share by Type in 2019
1.2.3 Routine Laboratory Tests
1.2.4 Inflammatory Markers
1.2.5 Autoantibodies & Immunologic Test
1.2.6 Other Tests
1.3 Global Diagnosis of Autoimmune Diseases Market by Application
1.3.1 Overview: Global Diagnosis of Autoimmune Diseases Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Rheumatoid Arthritis
1.3.3 Systemic Lupus Erythematosus
1.3.4 Sjögren’s Syndrome
1.3.5 Thyroiditis
1.3.6 Scleroderma
1.3.7 Other Diseases
1.4 Global Diagnosis of Autoimmune Diseases Market by Regions
1.4.1 Global Diagnosis of Autoimmune Diseases Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Diagnosis of Autoimmune Diseases (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Diagnosis of Autoimmune Diseases Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Diagnosis of Autoimmune Diseases Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Diagnosis of Autoimmune Diseases Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Diagnosis of Autoimmune Diseases Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Diagnosis of Autoimmune Diseases Status and Prospect (2015-2025)
1.5 COVID-19 Outbreak: Diagnosis of Autoimmune Diseases Industry Impact
1.5.1 COVID-19 Potential Implications for the Diagnosis of Autoimmune Diseases
1.5.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Diagnosis of Autoimmune Diseases
1.5.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.5.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.5.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.5.2 Opportunity Analysis in Covid-19 Crisis
1.5.3 Market Risk and Restraints
1.5.4 Market Driving Force
2 Company Profiles
2.1 Thermo Fisher Scientific
2.1.1 Thermo Fisher Scientific Details
2.1.2 Thermo Fisher Scientific Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Thermo Fisher Scientific SWOT Analysis
2.1.4 Thermo Fisher Scientific Product and Services
2.1.5 Thermo Fisher Scientific Diagnosis of Autoimmune Diseases Revenue, Gross Margin and Market Share (2018-2019)
2.2 Trinity Biotech
2.2.1 Trinity Biotech Details
2.2.2 Trinity Biotech Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Trinity Biotech SWOT Analysis
2.2.4 Trinity Biotech Product and Services
2.2.5 Trinity Biotech Diagnosis of Autoimmune Diseases Revenue, Gross Margin and Market Share (2018-2019)
2.3 GRIFOLS
2.3.1 GRIFOLS Details
2.3.2 GRIFOLS Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 GRIFOLS SWOT Analysis
2.3.4 GRIFOLS Product and Services
2.3.5 GRIFOLS Diagnosis of Autoimmune Diseases Revenue, Gross Margin and Market Share (2018-2019)
2.4 Siemens
2.4.1 Siemens Details
2.4.2 Siemens Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Siemens SWOT Analysis
2.4.4 Siemens Product and Services
2.4.5 Siemens Diagnosis of Autoimmune Diseases Revenue, Gross Margin and Market Share (2018-2019)
2.5 Abbott
2.5.1 Abbott Details
2.5.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Abbott SWOT Analysis
2.5.4 Abbott Product and Services
2.5.5 Abbott Diagnosis of Autoimmune Diseases Revenue, Gross Margin and Market Share (2018-2019)
2.6 Inova Diagnostics
2.6.1 Inova Diagnostics Details
2.6.2 Inova Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Inova Diagnostics SWOT Analysis
2.6.4 Inova Diagnostics Product and Services
2.6.5 Inova Diagnostics Diagnosis of Autoimmune Diseases Revenue, Gross Margin and Market Share (2018-2019)
2.7 Protagen
2.7.1 Protagen Details
2.7.2 Protagen Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Protagen SWOT Analysis
2.7.4 Protagen Product and Services
2.7.5 Protagen Diagnosis of Autoimmune Diseases Revenue, Gross Margin and Market Share (2018-2019)
2.8 Bio-Rad Laboratories
2.8.1 Bio-Rad Laboratories Details
2.8.2 Bio-Rad Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Bio-Rad Laboratories SWOT Analysis
2.8.4 Bio-Rad Laboratories Product and Services
2.8.5 Bio-Rad Laboratories Diagnosis of Autoimmune Diseases Revenue, Gross Margin and Market Share (2018-2019)
2.9 Danaher
2.9.1 Danaher Details
2.9.2 Danaher Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Danaher SWOT Analysis
2.9.4 Danaher Product and Services
2.9.5 Danaher Diagnosis of Autoimmune Diseases Revenue, Gross Margin and Market Share (2018-2019)
2.10 Werfen
2.10.1 Werfen Details
2.10.2 Werfen Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Werfen SWOT Analysis
2.10.4 Werfen Product and Services
2.10.5 Werfen Diagnosis of Autoimmune Diseases Revenue, Gross Margin and Market Share (2018-2019)
2.11 HYCOR Biomedical
2.11.1 HYCOR Biomedical Details
2.11.2 HYCOR Biomedical Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 HYCOR Biomedical SWOT Analysis
2.11.4 HYCOR Biomedical Product and Services
2.11.5 HYCOR Biomedical Diagnosis of Autoimmune Diseases Revenue, Gross Margin and Market Share (2018-2019)
2.12 HTG Molecular Diagnostics
2.12.1 HTG Molecular Diagnostics Details
2.12.2 HTG Molecular Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 HTG Molecular Diagnostics SWOT Analysis
2.12.4 HTG Molecular Diagnostics Product and Services
2.12.5 HTG Molecular Diagnostics Diagnosis of Autoimmune Diseases Revenue, Gross Margin and Market Share (2018-2019)
2.13 EUROIMMUN AG
2.13.1 EUROIMMUN AG Details
2.13.2 EUROIMMUN AG Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 EUROIMMUN AG SWOT Analysis
2.13.4 EUROIMMUN AG Product and Services
2.13.5 EUROIMMUN AG Diagnosis of Autoimmune Diseases Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Diagnosis of Autoimmune Diseases Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Diagnosis of Autoimmune Diseases Players Market Share
3.2.2 Top 10 Diagnosis of Autoimmune Diseases Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Diagnosis of Autoimmune Diseases Revenue and Market Share by Regions
4.2 North America Diagnosis of Autoimmune Diseases Revenue and Growth Rate (2015-2020)
4.3 Europe Diagnosis of Autoimmune Diseases Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Diagnosis of Autoimmune Diseases Revenue and Growth Rate (2015-2020)
4.5 South America Diagnosis of Autoimmune Diseases Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Diagnosis of Autoimmune Diseases Revenue and Growth Rate (2015-2020)
5 North America Diagnosis of Autoimmune Diseases Revenue by Countries
5.1 North America Diagnosis of Autoimmune Diseases Revenue by Countries (2015-2020)
5.2 USA Diagnosis of Autoimmune Diseases Revenue and Growth Rate (2015-2020)
5.3 Canada Diagnosis of Autoimmune Diseases Revenue and Growth Rate (2015-2020)
5.4 Mexico Diagnosis of Autoimmune Diseases Revenue and Growth Rate (2015-2020)
6 Europe Diagnosis of Autoimmune Diseases Revenue by Countries
6.1 Europe Diagnosis of Autoimmune Diseases Revenue by Countries (2015-2020)
6.2 Germany Diagnosis of Autoimmune Diseases Revenue and Growth Rate (2015-2020)
6.3 UK Diagnosis of Autoimmune Diseases Revenue and Growth Rate (2015-2020)
6.4 France Diagnosis of Autoimmune Diseases Revenue and Growth Rate (2015-2020)
6.5 Russia Diagnosis of Autoimmune Diseases Revenue and Growth Rate (2015-2020)
6.6 Italy Diagnosis of Autoimmune Diseases Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Diagnosis of Autoimmune Diseases Revenue by Countries
7.1 Asia-Pacific Diagnosis of Autoimmune Diseases Revenue by Countries (2015-2020)
7.2 China Diagnosis of Autoimmune Diseases Revenue and Growth Rate (2015-2020)
7.3 Japan Diagnosis of Autoimmune Diseases Revenue and Growth Rate (2015-2020)
7.4 Korea Diagnosis of Autoimmune Diseases Revenue and Growth Rate (2015-2020)
7.5 India Diagnosis of Autoimmune Diseases Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Diagnosis of Autoimmune Diseases Revenue and Growth Rate (2015-2020)
8 South America Diagnosis of Autoimmune Diseases Revenue by Countries
8.1 South America Diagnosis of Autoimmune Diseases Revenue by Countries (2015-2020)
8.2 Brazil Diagnosis of Autoimmune Diseases Revenue and Growth Rate (2015-2020)
8.3 Argentina Diagnosis of Autoimmune Diseases Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Diagnosis of Autoimmune Diseases by Countries
9.1 Middle East & Africa Diagnosis of Autoimmune Diseases Revenue by Countries (2015-2020)
9.2 Saudi Arabia Diagnosis of Autoimmune Diseases Revenue and Growth Rate (2015-2020)
9.3 UAE Diagnosis of Autoimmune Diseases Revenue and Growth Rate (2015-2020)
9.4 Egypt Diagnosis of Autoimmune Diseases Revenue and Growth Rate (2015-2020)
9.5 South Africa Diagnosis of Autoimmune Diseases Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Diagnosis of Autoimmune Diseases Revenue and Market Share by Type (2015-2020)
10.2 Global Diagnosis of Autoimmune Diseases Market Forecast by Type (2019-2024)
10.3 Routine Laboratory Tests Revenue Growth Rate (2015-2025)
10.4 Inflammatory Markers Revenue Growth Rate (2015-2025)
10.5 Autoantibodies & Immunologic Test Revenue Growth Rate (2015-2025)
10.6 Other Tests Revenue Growth Rate (2015-2025)
11 Global Diagnosis of Autoimmune Diseases Market Segment by Application
11.1 Global Diagnosis of Autoimmune Diseases Revenue Market Share by Application (2015-2020)
11.2 Diagnosis of Autoimmune Diseases Market Forecast by Application (2019-2024)
11.3 Rheumatoid Arthritis Revenue Growth (2015-2020)
11.4 Systemic Lupus Erythematosus Revenue Growth (2015-2020)
11.5 Sjögren’s Syndrome Revenue Growth (2015-2020)
11.6 Thyroiditis Revenue Growth (2015-2020)
11.7 Scleroderma Revenue Growth (2015-2020)
11.8 Other Diseases Revenue Growth (2015-2020)
12 Global Diagnosis of Autoimmune Diseases Market Size Forecast (2021-2025)
12.1 Global Diagnosis of Autoimmune Diseases Market Size Forecast (2021-2025)
12.2 Global Diagnosis of Autoimmune Diseases Market Forecast by Regions (2021-2025)
12.3 North America Diagnosis of Autoimmune Diseases Revenue Market Forecast (2021-2025)
12.4 Europe Diagnosis of Autoimmune Diseases Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Diagnosis of Autoimmune Diseases Revenue Market Forecast (2021-2025)
12.6 South America Diagnosis of Autoimmune Diseases Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Diagnosis of Autoimmune Diseases Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Diagnosis of Autoimmune Diseases Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Diagnosis of Autoimmune Diseases by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Diagnosis of Autoimmune Diseases Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Diagnosis of Autoimmune Diseases Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Diagnosis of Autoimmune Diseases Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Thermo Fisher Scientific Corporate Information, Location and Competitors
Table 7. Thermo Fisher Scientific Diagnosis of Autoimmune Diseases Major Business
Table 8. Thermo Fisher Scientific Diagnosis of Autoimmune Diseases Total Revenue (USD Million) (2017-2018)
Table 9. Thermo Fisher Scientific SWOT Analysis
Table 10. Thermo Fisher Scientific Diagnosis of Autoimmune Diseases Product and Solutions
Table 11. Thermo Fisher Scientific Diagnosis of Autoimmune Diseases Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Trinity Biotech Corporate Information, Location and Competitors
Table 13. Trinity Biotech Diagnosis of Autoimmune Diseases Major Business
Table 14. Trinity Biotech Diagnosis of Autoimmune Diseases Total Revenue (USD Million) (2018-2019)
Table 15. Trinity Biotech SWOT Analysis
Table 16. Trinity Biotech Diagnosis of Autoimmune Diseases Product and Solutions
Table 17. Trinity Biotech Diagnosis of Autoimmune Diseases Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. GRIFOLS Corporate Information, Location and Competitors
Table 19. GRIFOLS Diagnosis of Autoimmune Diseases Major Business
Table 20. GRIFOLS Diagnosis of Autoimmune Diseases Total Revenue (USD Million) (2017-2018)
Table 21. GRIFOLS SWOT Analysis
Table 22. GRIFOLS Diagnosis of Autoimmune Diseases Product and Solutions
Table 23. GRIFOLS Diagnosis of Autoimmune Diseases Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Siemens Corporate Information, Location and Competitors
Table 25. Siemens Diagnosis of Autoimmune Diseases Major Business
Table 26. Siemens Diagnosis of Autoimmune Diseases Total Revenue (USD Million) (2017-2018)
Table 27. Siemens SWOT Analysis
Table 28. Siemens Diagnosis of Autoimmune Diseases Product and Solutions
Table 29. Siemens Diagnosis of Autoimmune Diseases Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Abbott Corporate Information, Location and Competitors
Table 31. Abbott Diagnosis of Autoimmune Diseases Major Business
Table 32. Abbott Diagnosis of Autoimmune Diseases Total Revenue (USD Million) (2017-2018)
Table 33. Abbott SWOT Analysis
Table 34. Abbott Diagnosis of Autoimmune Diseases Product and Solutions
Table 35. Abbott Diagnosis of Autoimmune Diseases Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Inova Diagnostics Corporate Information, Location and Competitors
Table 37. Inova Diagnostics Diagnosis of Autoimmune Diseases Major Business
Table 38. Inova Diagnostics Diagnosis of Autoimmune Diseases Total Revenue (USD Million) (2017-2018)
Table 39. Inova Diagnostics SWOT Analysis
Table 40. Inova Diagnostics Diagnosis of Autoimmune Diseases Product and Solutions
Table 41. Inova Diagnostics Diagnosis of Autoimmune Diseases Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Protagen Corporate Information, Location and Competitors
Table 43. Protagen Diagnosis of Autoimmune Diseases Major Business
Table 44. Protagen Diagnosis of Autoimmune Diseases Total Revenue (USD Million) (2017-2018)
Table 45. Protagen SWOT Analysis
Table 46. Protagen Diagnosis of Autoimmune Diseases Product and Solutions
Table 47. Protagen Diagnosis of Autoimmune Diseases Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Bio-Rad Laboratories Corporate Information, Location and Competitors
Table 49. Bio-Rad Laboratories Diagnosis of Autoimmune Diseases Major Business
Table 50. Bio-Rad Laboratories Diagnosis of Autoimmune Diseases Total Revenue (USD Million) (2017-2018)
Table 51. Bio-Rad Laboratories SWOT Analysis
Table 52. Bio-Rad Laboratories Diagnosis of Autoimmune Diseases Product and Solutions
Table 53. Bio-Rad Laboratories Diagnosis of Autoimmune Diseases Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Danaher Corporate Information, Location and Competitors
Table 55. Danaher Diagnosis of Autoimmune Diseases Major Business
Table 56. Danaher Diagnosis of Autoimmune Diseases Total Revenue (USD Million) (2017-2018)
Table 57. Danaher SWOT Analysis
Table 58. Danaher Diagnosis of Autoimmune Diseases Product and Solutions
Table 59. Danaher Diagnosis of Autoimmune Diseases Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Werfen Corporate Information, Location and Competitors
Table 61. Werfen Diagnosis of Autoimmune Diseases Major Business
Table 62. Werfen Diagnosis of Autoimmune Diseases Total Revenue (USD Million) (2017-2018)
Table 63. Werfen SWOT Analysis
Table 64. Werfen Diagnosis of Autoimmune Diseases Product and Solutions
Table 65. Werfen Diagnosis of Autoimmune Diseases Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. HYCOR Biomedical Corporate Information, Location and Competitors
Table 67. HYCOR Biomedical Diagnosis of Autoimmune Diseases Major Business
Table 68. HYCOR Biomedical Diagnosis of Autoimmune Diseases Total Revenue (USD Million) (2017-2018)
Table 69. HYCOR Biomedical SWOT Analysis
Table 70. HYCOR Biomedical Diagnosis of Autoimmune Diseases Product and Solutions
Table 71. HYCOR Biomedical Diagnosis of Autoimmune Diseases Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 72. HTG Molecular Diagnostics Corporate Information, Location and Competitors
Table 73. HTG Molecular Diagnostics Diagnosis of Autoimmune Diseases Major Business
Table 74. HTG Molecular Diagnostics Diagnosis of Autoimmune Diseases Total Revenue (USD Million) (2017-2018)
Table 75. HTG Molecular Diagnostics SWOT Analysis
Table 76. HTG Molecular Diagnostics Diagnosis of Autoimmune Diseases Product and Solutions
Table 77. HTG Molecular Diagnostics Diagnosis of Autoimmune Diseases Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 78. EUROIMMUN AG Corporate Information, Location and Competitors
Table 79. EUROIMMUN AG Diagnosis of Autoimmune Diseases Major Business
Table 80. EUROIMMUN AG Diagnosis of Autoimmune Diseases Total Revenue (USD Million) (2017-2018)
Table 81. EUROIMMUN AG SWOT Analysis
Table 82. EUROIMMUN AG Diagnosis of Autoimmune Diseases Product and Solutions
Table 83. EUROIMMUN AG Diagnosis of Autoimmune Diseases Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 84. Global Diagnosis of Autoimmune Diseases Revenue (Million USD) by Players (2015-2020)
Table 85. Global Diagnosis of Autoimmune Diseases Revenue Share by Players (2015-2020)
Table 86. Global Diagnosis of Autoimmune Diseases Revenue (Million USD) by Regions (2015-2020)
Table 87. Global Diagnosis of Autoimmune Diseases Revenue Market Share by Regions (2015-2020)
Table 88. North America Diagnosis of Autoimmune Diseases Revenue by Countries (2015-2020)
Table 89. North America Diagnosis of Autoimmune Diseases Revenue Market Share by Countries (2015-2020)
Table 90. Europe Diagnosis of Autoimmune Diseases Revenue (Million USD) by Countries (2015-2020)
Table 91. Asia-Pacific Diagnosis of Autoimmune Diseases Revenue (Million USD) by Countries (2015-2020)
Table 92. South America Diagnosis of Autoimmune Diseases Revenue by Countries (2015-2020)
Table 93. South America Diagnosis of Autoimmune Diseases Revenue Market Share by Countries (2015-2020)
Table 94. Middle East and Africa Diagnosis of Autoimmune Diseases Revenue (Million USD) by Countries (2015-2020)
Table 95. Middle East and Africa Diagnosis of Autoimmune Diseases Revenue Market Share by Countries (2015-2020)
Table 96. Global Diagnosis of Autoimmune Diseases Revenue (Million USD) by Type (2015-2020)
Table 97. Global Diagnosis of Autoimmune Diseases Revenue Share by Type (2015-2020)
Table 98. Global Diagnosis of Autoimmune Diseases Revenue Forecast by Type (2021-2025)
Table 99. Global Diagnosis of Autoimmune Diseases Revenue by Application (2015-2020)
Table 100. Global Diagnosis of Autoimmune Diseases Revenue Share by Application (2015-2020)
Table 101. Global Diagnosis of Autoimmune Diseases Revenue Forecast by Application (2021-2025)
Table 102. Global Diagnosis of Autoimmune Diseases Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Diagnosis of Autoimmune Diseases Picture
Figure 2. Global Diagnosis of Autoimmune Diseases Revenue Market Share by Type in 2019
Figure 3. Routine Laboratory Tests Picture
Figure 4. Inflammatory Markers Picture
Figure 5. Autoantibodies & Immunologic Test Picture
Figure 6. Other Tests Picture
Figure 7. Diagnosis of Autoimmune Diseases Revenue Market Share by Application in 2019
Figure 8. Rheumatoid Arthritis Picture
Figure 9. Systemic Lupus Erythematosus Picture
Figure 10. Sjögren’s Syndrome Picture
Figure 11. Thyroiditis Picture
Figure 12. Scleroderma Picture
Figure 13. Other Diseases Picture
Figure 14. Global Diagnosis of Autoimmune Diseases Revenue (USD Million) and Growth Rate (2015-2025)
Figure 15. North America Diagnosis of Autoimmune Diseases Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Europe Diagnosis of Autoimmune Diseases Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Asia-Pacific Diagnosis of Autoimmune Diseases Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. South America Diagnosis of Autoimmune Diseases Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Middle East and Africa Diagnosis of Autoimmune Diseases Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Global Diagnosis of Autoimmune Diseases Revenue (Million USD) and Growth Rate (2015-2025)
Figure 21. Global Diagnosis of Autoimmune Diseases Revenue Share by Players in 2019
Figure 22. Global Top 5 Players Diagnosis of Autoimmune Diseases Revenue Market Share in 2019
Figure 23. Global Top 10 Players Diagnosis of Autoimmune Diseases Revenue Market Share in 2019
Figure 24. Key Players Market Share Trend
Figure 25. Global Diagnosis of Autoimmune Diseases Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 26. Global Diagnosis of Autoimmune Diseases Revenue Market Share by Regions (2015-2020)
Figure 27. Global Diagnosis of Autoimmune Diseases Revenue Market Share by Regions in 2018
Figure 28. North America Diagnosis of Autoimmune Diseases Revenue and Growth Rate (2015-2020)
Figure 29. Europe Diagnosis of Autoimmune Diseases Revenue and Growth Rate (2015-2020)
Figure 30. Asia-Pacific Diagnosis of Autoimmune Diseases Revenue and Growth Rate (2015-2020)
Figure 31. South America Diagnosis of Autoimmune Diseases Revenue and Growth Rate (2015-2020)
Figure 32. Middle East and Africa Diagnosis of Autoimmune Diseases Revenue and Growth Rate (2015-2020)
Figure 33. North America Diagnosis of Autoimmune Diseases Revenue Market Share by Countries (2015-2020)
Figure 34. North America Diagnosis of Autoimmune Diseases Revenue Market Share by Countries in 2019
Figure 35. USA Diagnosis of Autoimmune Diseases Revenue and Growth Rate (2015-2020)
Figure 36. Canada Diagnosis of Autoimmune Diseases Revenue and Growth Rate (2015-2020)
Figure 37. Mexico Diagnosis of Autoimmune Diseases Revenue and Growth Rate (2015-2020)
Figure 38. Europe Diagnosis of Autoimmune Diseases Revenue Market Share by Countries (2015-2020)
Figure 39. Europe Diagnosis of Autoimmune Diseases Revenue Market Share by Countries in 2019
Figure 40. Germany Diagnosis of Autoimmune Diseases Revenue and Growth Rate (2015-2020)
Figure 41. UK Diagnosis of Autoimmune Diseases Revenue and Growth Rate (2015-2020)
Figure 42. France Diagnosis of Autoimmune Diseases Revenue and Growth Rate (2015-2020)
Figure 43. Russia Diagnosis of Autoimmune Diseases Revenue and Growth Rate (2015-2020)
Figure 44. Italy Diagnosis of Autoimmune Diseases Revenue and Growth Rate (2015-2020)
Figure 45. Asia-Pacific Diagnosis of Autoimmune Diseases Revenue Market Share by Countries (2015-2020)
Figure 46. Asia-Pacific Diagnosis of Autoimmune Diseases Revenue Market Share by Countries in 2019
Figure 47. China Diagnosis of Autoimmune Diseases Revenue and Growth Rate (2015-2020)
Figure 48. Japan Diagnosis of Autoimmune Diseases Revenue and Growth Rate (2015-2020)
Figure 49. Korea Diagnosis of Autoimmune Diseases Revenue and Growth Rate (2015-2020)
Figure 50. India Diagnosis of Autoimmune Diseases Revenue and Growth Rate (2015-2020)
Figure 51. Southeast Asia Diagnosis of Autoimmune Diseases Revenue and Growth Rate (2015-2020)
Figure 52. South America Diagnosis of Autoimmune Diseases Revenue Market Share by Countries (2015-2020)
Figure 53. South America Diagnosis of Autoimmune Diseases Revenue Market Share by Countries in 2019
Figure 54. Brazil Diagnosis of Autoimmune Diseases Revenue and Growth Rate (2015-2020)
Figure 55. Argentina Diagnosis of Autoimmune Diseases Revenue and Growth Rate (2015-2020)
Figure 56. Middle East and Africa Diagnosis of Autoimmune Diseases Revenue Market Share by Countries (2015-2020)
Figure 57. Middle East and Africa Diagnosis of Autoimmune Diseases Revenue Market Share by Countries in 2019
Figure 58. Saudi Arabia Diagnosis of Autoimmune Diseases Revenue and Growth Rate (2015-2020)
Figure 59. UAE Diagnosis of Autoimmune Diseases Revenue and Growth Rate (2015-2020)
Figure 60. Egypt Diagnosis of Autoimmune Diseases Revenue and Growth Rate (2015-2020)
Figure 61. South Africa Diagnosis of Autoimmune Diseases Revenue and Growth Rate (2015-2020)
Figure 62. Global Diagnosis of Autoimmune Diseases Revenue Share by Type (2015-2020)
Figure 63. Global Diagnosis of Autoimmune Diseases Revenue Share by Type in 2019
Figure 64. Global Diagnosis of Autoimmune Diseases Market Share Forecast by Type (2021-2025)
Figure 65. Global Routine Laboratory Tests Revenue Growth Rate (2015-2020)
Figure 66. Global Inflammatory Markers Revenue Growth Rate (2015-2020)
Figure 67. Global Autoantibodies & Immunologic Test Revenue Growth Rate (2015-2020)
Figure 68. Global Other Tests Revenue Growth Rate (2015-2020)
Figure 69. Global Diagnosis of Autoimmune Diseases Revenue Share by Application (2015-2020)
Figure 70. Global Diagnosis of Autoimmune Diseases Revenue Share by Application in 2019
Figure 71. Global Diagnosis of Autoimmune Diseases Market Share Forecast by Application (2021-2025)
Figure 72. Global Rheumatoid Arthritis Revenue Growth Rate (2015-2020)
Figure 73. Global Systemic Lupus Erythematosus Revenue Growth Rate (2015-2020)
Figure 74. Global Sjögren’s Syndrome Revenue Growth Rate (2015-2020)
Figure 75. Global Thyroiditis Revenue Growth Rate (2015-2020)
Figure 76. Global Scleroderma Revenue Growth Rate (2015-2020)
Figure 77. Global Other Diseases Revenue Growth Rate (2015-2020)
Figure 78. Global Diagnosis of Autoimmune Diseases Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 79. Global Diagnosis of Autoimmune Diseases Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 80. Global Diagnosis of Autoimmune Diseases Revenue Market Share Forecast by Regions (2021-2025)
Figure 81. North America Diagnosis of Autoimmune Diseases Revenue Market Forecast (2021-2025)
Figure 82. Europe Diagnosis of Autoimmune Diseases Revenue Market Forecast (2021-2025)
Figure 83. Asia-Pacific Diagnosis of Autoimmune Diseases Revenue Market Forecast (2021-2025)
Figure 84. South America Diagnosis of Autoimmune Diseases Revenue Market Forecast (2021-2025)
Figure 85. Middle East and Africa Diagnosis of Autoimmune Diseases Revenue Market Forecast (2021-2025)
Figure 86. Sales Channel: Direct Channel vs Indirect Channel
自己免疫疾患治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Autoimmune Disorders Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Autoimmune Dis…- 自己免疫治療薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Autoimmune Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Autoimmune Drugs market repo…
- 関節リウマチ診断検査の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Rheumatoid Arthritis Diagnosis Tests market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.0% in the forecast period of 2020 to 2025 and will expected to reach USD 529.2 million by 2025, from USD 435.8 million in 2019. The R…
- HIV診断及び治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global HIV Diagnosis & Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The HIV Diagnosis & Tre…
- 着床前遺伝子診断（PGD）の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Pre-Implantation Genetic Diagnosis (PGD) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value …